İsteğe bağlı ürün analizi
İzninizle, hangi araştırma yolculuklarının işe yaradığını anlamak için gizliliği gözeten sınırlı analizler kullanırız. Reklam izleyicileri veya oturum kaydı kullanmayız. Bu seçimi Tercihler bölümünden değiştirebilirsiniz. Okuyun Gizlilik Politikası.
Ulta Beauty Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $23.3B | |
|---|---|---|
| Revenue (ttm) | 13B | |
| Net income (ttm) | 1.2B | |
| EPS (ttm) | $27.4 | |
| Shares out | 42.8M | |
| P/E (trailing) | 22.5x | |
| P/E (forward) | 19.6x | |
| Volume | 348,647 | |
| Beta | 0.84 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-29 | 2023-01-28 | 2024-02-03 | 2025-02-01 | 2026-01-31 | Trend |
| Revenue | $8.63B | $10.21B | $11.21B | $11.30B | $12.39B | +9.5% |
| Gross profit | $3.37B | $4.04B | $4.38B | $4.39B | $4.85B | +9.5% |
| Operating income | $1.30B | $1.64B | $1.68B | $1.56B | $1.53B | +4.3% |
| Net income | $985.8M | $1.24B | $1.29B | $1.20B | $1.15B | +4.0% |
| EPS (diluted) | $17.98 | $24.01 | $26.03 | $25.34 | $25.64 | +9.3% |
| EBITDA | $1.57B | $1.88B | $1.94B | $1.85B | $1.83B | +4.0% |
| R&D | $926.0K | $1.0M | $889.0K | $306.0K | — | -30.9% |
| SG&A | $2.06B | $2.40B | $2.69B | $2.81B | $3.30B | +12.5% |
Recent company headlines from major financial publishers.
Net sales compound moderately and operating margins remain stable. Store-fulfilled digital orders leverage retail fixed overhead, counterbalanced by persistent promotional activity. Substantial free cash flow generation and disciplined share repurchases support steady per-share compounding through FY2028.
Prestige beauty product innovation, category expansion into wellness routines, and store-fulfilled digital efficiencies drive accelerating comparable store sales growth and operating margin expansion, supporting robust earnings compounding alongside authorized capital return programs.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.2% | $520 | $532 | $544 | $558 | $573 |
| 8.7% | $493 | $502 | $513 | $524 | $536 |
| 9.2% | $470 | $477 | $486 | $495 | $505 |
| 9.7% | $449 | $456 | $463 | $470 | $479 |
| 10.2% | $431 | $437 | $443 | $449 | $456 |
Upcoming earnings date and setup when available.
Her ay yayımlanan araştırma sürümünün taşıdığı derecelendirme. Bir derecelendirme, analiz tarihindeki fiyatı gerçeğe uygun değerle karşılaştırır; tahminin doğru çıkıp çıkmadığının kaydı değildir.
| Yıl | Oca | Şub | Mar | Nis | May | Haz | Tem | Ağu | Eyl | Eki | Kas | Ara |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |